Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Alkermes plc's Expenses

Cost Insights: Walgreens Boots Alliance, Inc. vs. Alkermes plc

In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding cost dynamics is crucial. Walgreens Boots Alliance, Inc., a global leader in retail pharmacy, and Alkermes plc, a biopharmaceutical company, present intriguing contrasts in their cost structures over the past decade.

From 2014 to 2023, Walgreens Boots Alliance consistently reported a cost of revenue that dwarfed Alkermes by over 100 times, reflecting its expansive retail operations. Notably, Walgreens saw a 104% increase in costs from 2014 to 2023, peaking in 2024. In contrast, Alkermes experienced a more volatile trajectory, with costs peaking in 2019 and then dropping by 64% by 2023.

These trends highlight the differing challenges and strategies in managing costs within the pharmaceutical and retail sectors. As we look to the future, understanding these dynamics will be key for investors and industry stakeholders.